Enough with data collection, FDA needs diversity policies to boost representation in clinical trials: report

Home / Intelligence / Industry Publications / Enough with data collection, FDA needs diversity policies to boost representation in clinical trials: report

Trinity’s recent white paper, titled Diversity in Clinical Trials Participation: A Life Sciences Perspective, was featured in a recent article by Fierce Biotech.

Related Intelligence